Literature DB >> 14732428

"Who gets in?" Recruitment and screening processes of outpatient substance abuse trials.

Shelly L Sayre1, Mark Evans, Patricia S Hokanson, Joy M Schmitz, Angela L Stotts, Patricia Averill, John Grabowski.   

Abstract

A brief telephone-screening interview was conducted with 1759 callers seeking treatment for substance abuse at the Treatment Research Clinic (TRC) over a 16-month period. The purpose of this study was to examine the effectiveness of various recruitment methods in attracting eligible participants and to identify screening variables that characterized eligible and ineligible callers. Callers referred by friends and family were more likely to be eligible than callers from other referral sources. Callers seeking treatment for cocaine abuse who reported more severe alcohol/substance problems were more likely to be eligible for treatment protocols, while those with severe problems in other psychosocial areas (legal, medical, and psychiatric) were more often excluded. Alcohol- and nicotine-dependent callers reporting severe alcohol problems were more likely to be eligible but otherwise were not different from callers who were ineligible. The effectiveness of recruitment methods may not be the same for different types of substance use disorders. This study underscores the importance of having a sensitive screening assessment for recruiting a homogeneous yet representative sample for outpatient substance abuse clinical trials.

Entities:  

Mesh:

Year:  2004        PMID: 14732428     DOI: 10.1016/j.addbeh.2003.08.010

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  8 in total

1.  Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis.

Authors:  D Andrew Tompkins; Jessica A Sides; Joseph A Harrison; Eric C Strain
Journal:  Addict Disord Their Treat       Date:  2015-12

Review 2.  Interventions for recruiting smokers into cessation programmes.

Authors:  José S Marcano Belisario; Michelle N Bruggeling; Laura H Gunn; Serena Brusamento; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

3.  Working memory fMRI activation in cocaine-dependent subjects: association with treatment response.

Authors:  F Gerard Moeller; Joel L Steinberg; Joy M Schmitz; Liangsuo Ma; Shijing Liu; Kimberly L Kjome; Nuvan Rathnayaka; Larry A Kramer; Ponnada A Narayana
Journal:  Psychiatry Res       Date:  2010-02-12       Impact factor: 3.222

4.  Measuring the level of diagnostic concordance and discordance between modules of the CIDI-Short Form and the CIDI-Auto 2.1.

Authors:  Matthew Sunderland; Gavin Andrews; Tim Slade; Lorna Peters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-06-18       Impact factor: 4.328

5.  Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants.

Authors:  John J Mariani; Wendy Y Cheng; Adam Bisaga; Maria Sullivan; Kenneth Carpenter; Edward V Nunes; Frances R Levin
Journal:  J Subst Abuse Treat       Date:  2011-03-24

6.  A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.

Authors:  Joy M Schmitz; Charles E Green; Angela L Stotts; Jan A Lindsay; Nuvan S Rathnayaka; John Grabowski; F Gerard Moeller
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

7.  High-dose naltrexone therapy for cocaine-alcohol dependence.

Authors:  Joy M Schmitz; Jan A Lindsay; Charles E Green; David V Herin; Angela L Stotts; F Gerard Moeller
Journal:  Am J Addict       Date:  2009 Sep-Oct

8.  Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation.

Authors:  Joy M Schmitz; Nuvan Rathnayaka; Charles E Green; F Gerard Moeller; Anne E Dougherty; John Grabowski
Journal:  Front Psychiatry       Date:  2012-08-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.